Nasal immunization with different forms of heat shock protein-65 reduced high-cholesterol-diet-driven rabbit atherosclerosis

International Immunopharmacology

Volumn 13, Issue 1, 2012, Pages 82-87

  Long, Jun ^a   Lin, Jie ^b   Yang, Xin ^c   Yuan, Dongping ^a   Wu, Jie ^c   Li, Taiming ^c   Cao, Rongyue ^c   Liu, Jingjing ^c  

^a NANJING UNIVERSITY OF CHINESE MEDICINE   (China)

^b YUNNAN UNIVERSITY   (China)

^c CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Atherosclerosis; Heat shock protein 65; Inoculation method; Nasal immunization

Indexed keywords

CHOLESTEROL; DNA VACCINE; GAMMA INTERFERON; HEAT SHOCK PROTEIN 65; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; INTERLEUKIN 10; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY AFFINITY; ANTIBODY RESPONSE; ANTIBODY TITER; ANTIGEN ANTIBODY REACTION; AORTA; ARTICLE; ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL DIET; CONTROLLED STUDY; CYTOKINE PRODUCTION; DNA IMMUNIZATION; EXPERIMENTAL RABBIT; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOLOGICAL TOLERANCE; INOCULATION; MALE; NONHUMAN; NOSE CAVITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRIACYLGLYCEROL BLOOD LEVEL;

ADMINISTRATION, INTRANASAL; ANIMALS; ANTIBODY AFFINITY; AORTA; ATHEROSCLEROSIS; BACTERIAL PROTEINS; CHAPERONIN 60; CHOLESTEROL, DIETARY; CYTOKINES; DIET, ATHEROGENIC; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; IMMUNIZATION; IMMUNOGLOBULIN G; LIPIDS; MALE; NASAL MUCOSA; RABBITS; VACCINES;

EID: 84859311500     PISSN: 15675769     EISSN: 18781705     Source Type: Journal    
DOI: 10.1016/j.intimp.2012.03.008     Document Type: Article

References (43)

1. R. Ross Atherosclerosis-an inflammatory disease N Engl J Med 340 1999 115 126
2. C.J. Binder, M.K. Chang, P.X. Shaw, Y.I. Miller, K. Hartvigsen, and A. Dewan Innate and acquired immunity in atherogenesis Nat Med 8 2002 1218 1226
3. G.K. Hansson, P. Libby, U. Schonbeck, and Z.Q. Yan Innate and adaptive immunity in the pathogenesis of atherosclerosis Circ Res 91 2002 281 291
4. P. Libby Inflammation in atherosclerosis Nature 420 2002 868 874
5. G.H. Van Puijvelde, T. van Es, K.L. Habets, A.D. Hauer, T.J. van Berkel, and J. Kuiper A vaccine against atherosclerosis: myth or reality? Future Cardiol 4 2008 125 133
6. G. Wick, M. Romen, A. Amberger, B. Metzler, M. Mayr, and G. Falkensammer Atherosclerosis, autoimmunity, and vascular-associated lymphoid tissue FASEB J 11 1997 1199 1207
7. A.G. Pockley Heat shock proteins, inflammation, and cardiovascular disease Circulation 105 2002 1012 1017
8. J.B. Winfield, and W.N. Jarjour Stress proteins, autoimmunity, and autoimmune disease Curr Top Microbiol Immunol 167 1991 161 189
9. P.A. Berberian, W. Myers, M. Tytell, V. Challa, and M.G. Bond Immunohistochemical localization of heat shock protein-70 in normal-appearing and atherosclerotic specimens of human arteries Am J Pathol 136 1990 71 80
10. Q. Xu, J. Willeit, M. Marosi, R. Kleindienst, F. Oberhollenzer, and S. Kiechl Association of serum antibodies to heat-shock protein 65 with carotid atherosclerosis Lancet 341 1993 255 259
11. Q. Xu, H. Dietrich, H.J. Steiner, A.M. Gown, B. Schoel, and G. Mikuz Induction of arteriosclerosis in normocholesterolemic rabbits by immunization with heat shock protein 65 Arterioscler Thromb 12 1992 789 799
12. J. George, Y. Shoenfeld, A. Afek, B. Gilburd, P. Keren, and A. Shaish Enhanced fatty streak formation in C57BL/6J mice by immunization with heat shock protein-65 Arterioscler Thromb Vasc Biol 19 1999 505 510
13. Q. Xu, S. Kiechl, M. Mayr, B. Metzler, G. Egger, and F. Oberhollenzer Association of serum antibodies to heat-shock protein 65 with carotid atherosclerosis: clinical significance determined in a follow-up study Circulation 100 1999 1169 1174
14. Q. Gaofu, L. Jun, Y. Xin, L. Wentao, W. Jie, and Z. Xiuyun Vaccinating rabbits with a cholesteryl ester transfer protein (CETP) B-Cell epitope carried by heat shock protein-65 (Hsp65) for inducing anti-CETP antibodies and reducing aortic lesions in vivo J Cardiovasc Pharmacol 45 2005 591 598
15. Q. Gaofu, L. Jun, Z. Xiuyun, L. Wentao, W. Jie, and L. Jingjing Antibody against cholesteryl ester transfer protein (CETP) elicited by a recombinant chimeric enzyme vaccine attenuated atherosclerosis in a rabbit model Life Sci 77 2005 2690 2702
16. A. Afek, J. George, B. Gilburd, L. Rauova, I. Goldberg, and J. Kopolovic Immunization of low-density lipoprotein receptor deficient (LDL-RD) mice with heat shock protein 65 (HSP-65) promotes early atherosclerosis J Autoimmun 14 2000 115 121
17. D. Harats, N. Yacov, B. Gilburd, Y. Shoenfeld, and J. George Oral tolerance with heat shock protein 65 attenuates Mycobacterium tuberculosis-induced and high-fat-diet-driven atherosclerotic lesions J Am Coll Cardiol 40 2002 1333 1338
18. R. Maron, G. Sukhova, A.M. Faria, E. Hoffmann, F. Mach, and P. Libby Mucosal administration of heat shock protein-65 decreases atherosclerosis and inflammation in aortic arch of low-density lipoprotein receptor-deficient mice Circulation 106 2002 1708 1715
19. G.H. Van Puijvelde, T. van Es, E.J. van Wanrooij, K.L. Habets, P. de Vos, and R. van der Zee Induction of oral tolerance to HSP60 or an HSP60-peptide activates T cell regulation and reduces atherosclerosis Arterioscler Thromb Vasc Biol 27 2007 2677 2683
20. Z. Mallat, H. Ait-Oufella, and A. Tedgui Regulatory T cell responses: potential role in the control of atherosclerosis Curr Opin Lipidol 16 2005 518 524
21. H. Ait-Oufella, B.L. Salomon, S. Potteaux, A.K. Robertson, P. Gourdy, and J. Zoll Natural regulatory T cells control the development of atherosclerosis in mice Nat Med 12 2006 178 180
22. H. Yi, Y. Rong, Z. Yankai, L. Wentao, Z. Hongxia, and W. Jie Improved efficacy of DNA vaccination against breast cancer by boosting with the repeat beta-hCG C-terminal peptide carried by mycobacterial heat-shock protein HSP65 Vaccine 24 2006 2575 2584
23. Q. Gaofu, M. Dan, W. Jie, Z. Liao, Z. Li, and R.S. Roque Long-lasting specific antibodies against CETP induced by subcutaneous and mucosal administration of a 26-amino acid CETP epitope carried by heat shock protein 65 kDa in the absence of adjuvants Vaccine 22 2004 3187 3194
24. G.R. Pullen, M.G. Fitzgerald, and C.S. Hosking Antibody avidity determination by ELISA using thiocyanate elution J Immunol Methods 86 1986 83 87
25. C.A. Lobo, R. Dhar, and N. Kumar Immunization of mice with DNA-based Pfs25 elicits potent malaria transmission-blocking antibodies Infect Immun 67 1999 1688 1693
26. Q. Xu, and G. Wick The role of heat shock proteins in protection and pathophysiology of the arterial wall Mol Med Today 2 1996 372 379
27. Q. Xiong, J. Li, L. Jin, J. Liu, and T. Li Nasal immunization with heat shock protein 65 attenuates atherosclerosis and reduces serum lipids in cholesterol-fed wild-type rabbits probably through different mechanisms Immunol Lett 125 2009 40 45
28. R. Kiessling, A. Grönberg, J. Ivanyi, K. Söderström, M. Ferm, and S. Kleinau Role of hsp60 during autoimmune and bacterial inflammation Immunol Rev 121 1991 91 111
29. J.T. Salonen, S. Ylä-Herttuala, R. Yamamoto, S. Butler, H. Korpela, and R. Salonen Autoantibody against oxidised LDL and progression of carotid atherosclerosis Lancet 339 1992 883 887
30. G. Wick, G. Schett, A. Amberger, R. Kleindienst, and Q. Xu Is atherosclerosis an immunologically mediated disease? Immunol Today 16 1995 27 33
31. J. Frostegård, B. Kjellman, M. Gidlund, B. Andersson, S. Jindal, and R. Kiessling Induction of heat shock protein in monocytic cells by oxidized low density lipoprotein Atherosclerosis 121 1996 93 103
32. J. George, A. Afek, B. Gilburd, M. Blank, Y. Levy, and A. Aron-Maor Induction of early atherosclerosis in LDL-receptor-deficient mice immunized with beta2-glycoprotein I Circulation 98 1998 1108 1115
33. H.L. Weiner Oral tolerance for the treatment of autoimmune diseases Annu Rev Med 48 1997 341 351
34. A.M. Faria, and H.L. Weiner Oral tolerance: mechanisms and therapeutic applications Adv Immunol 73 1999 153 264
35. R.D. Weeratna, M.J. McCluskie, Y. Xu, and H.L. Davis CpG DNA induces stronger immune responses with less toxicity than other adjuvants Vaccine 18 2000 1755 1762
36. M.J. McCluskie, R.D. Weeratna, and H.L. Davis The potential of oligodeoxynucleotides as mucosal and parenteral adjuvants Vaccine 19 2001 2657 2660
37. M.J. McCluskie, and H.L. Davis Oral, intrarectal and intranasal immunization using CpG and non-CpG oligodeoxynucleotides as adjuvants Vaccine 19 2000 413 422
38. K.R. Feingold, and C. Grunfeld Tumor necrosis factor-alpha stimulates hepatic lipogenesis in the rat in vivo J Clin Invest 80 1987 184 190
39. K.R. Feingold, M. Soued, S. Adi, I. Staprans, R. Neese, and J. Shigenaga Effect of interleukin-1 on lipid metabolism in the rat: similarities to and differences from tumor necrosis factor Arterioscler Thromb 11 1991 495 500
40. K. Nonogaki, G.M. Fuller, N.L. Fuentes, A.H. Moser, I. Staprans, and C. Grunfeld Interleukin-6 stimulates hepatic triglyceride secretion in rats Endocrinology 136 1995 2143 2149
41. R. Kurzrock, M.F. Rohde, J.R. Quesada, S.H. Gianturco, W.A. Bradley, and S.A. Sherwin Recombinant gamma interferon induces hypertriglyceridemia and inhibits post-heparin lipase activity in cancer patients J Exp Med 164 1986 1093 1101
42. E.A. Olsen, G.R. Lichtenstein, and W.E. Wilkinson Changes in serum lipids in patients with condylomata acuminata treated with interferon alfa-n1 (Wellferon) J Am Acad Dermatol 19 1988 286 289
43. J.H. Von Der Thüsen, J. Kuiper, M.L. Fekkes, P. De Vos, T.J. Van Berkel, and E.A. Biessen Attenuation of atherogenesis by systemic and local adenovirus-mediated gene transfer of interleukin-10 in LDLr-/- mice FASEB J 15 2001 2730 2732